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Abstract
Signals delivered by the CD40 ligand, CD154, have crucial roles in immune responses in mammals, being required for
development of germinal centres, maturation of T-dependent antibody responses, and generation of B-cell memory. To
determine whether these functions were conserved in a non-mammalian species, a putative chicken CD154 cDNA was used to
make an oligomeric fusion protein, and to raise monoclonal antibodies. The antibodies detected surface expression on activated
T-cells. The fusion protein detected expression of a receptor on B-cells, thrombocytes and macrophages. Biological effects of
the fusion protein included induction of NO synthesis in a macrophage cell line, enhancement of splenic B-cell survival, and
induction of apoptosis in a bursal lymphoma cell line. These observations demonstrated substantial functional equivalence with
mammalian CD154 and thus provided evidence for the early evolutionary emergence of the set of functions associated with this
molecule, and its central role in the vertebrate immune system.
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1. Introduction
Several of the 18 known members of the TNF
superfamily [1] have important functions in the
development and regulation of the immune system
and its responses. These functions are essentially
determined by the signalling properties and
expression profiles of their receptors, members of
the TNFR superfamily [2]. TNF family members
share a low degree of sequence similarity, with the
majority of conserved residues involved in maintain-
ing the structure of the C terminal TNF domain [3].
The majority of these proteins are type II transmem-
brane proteins, although one is secreted [4], and
several others may be cleaved from the membrane by
proteases and released as soluble proteins [2].
The TNF superfamily member CD154 (CD40L)
has several essential functions in the regulation of
immune responses in mammals [5], as clearly
evidenced by the severe consequences of inactivating
mutations in X-linked hyper IgM syndrome [6]. It is
required for the formation of germinal centres, and
thus for affinity maturation of antibodies and the
generation of class-switched memory B-cells in T-cell
dependent humoral responses [7]. It can also provide
signals for the maturation of dendritic cells [8], thus
playing an important role in the initiation of T-cell
responses. As well as B-cells and other antigen-
presenting cells, a variety of non-immune cells also
express CD40, the cognate receptor for CD154, and
can respond to a CD154 stimulus by secreting pro-
inflammatory cytokines [9,10]. In contrast to the wide
tissue and cell distribution of CD40, CD154 was
initially reported to be expressed by activated T-cells
[11,12], although expression has now been shown on
several other cell types [5].
Despite basic similarities, there are some important
differences between the immune systems of mammals
and birds. These may imply differences in the set of
molecules involved in regulation of the immune
system and their functions. For example, the TNF
family member lymphotoxin-a is essential, in mice,
for the development of classical lymph nodes, which
are absent in chickens [13]. Other examples are
provided by the smaller family of Ig constant regions
in the chicken [14], the chicken MHC [15], chemo-
kines and their receptors [16] (N. Bumstead personal
communication).
Having identified a possible orthologue of CD154
in chickens, on the basis of sequence analysis, we
needed to investigate its functional properties in order
to determine whether function was also conserved. A
number of different engineered soluble CD154
proteins have been used in studies of the functions
of this molecule [17–19], which have shown that the
protein is active only in the form of a trimer, formed
by non-covalent interactions between the TNF
domains of the monomer, and that higher degrees of
oligomerisation may be required for some signalling
functions [20]. We prepared a soluble fusion protein
consisting of the extra-cellular domain of mouse
CD8a joined to the extra-cellular domain of the
putative chicken CD154. This molecule, analogous to
similar fusions with mammalian CD154 that have
biological activity, bound to a chicken CD40-Ig
fusion protein. It was used to study the functions of
the chicken CD154-like molecule, to determine
whether some of the functional properties of the
molecule were conserved, and thus whether the role of
this molecule was established before the divergence
of birds and mammals.
2. Methods
2.1. Reagents
A cDNA library was prepared from purified
splenocytes of a normal juvenile RPRL Line 0 inbred
White Leghorn bird, in the mammalian cell expression
vector pcInX as described elsewhere [21,22]. A cDNA
clone containing the coding sequence for mouse CD8a
[23] was a kind gift from Dr R. Zamoyska (NIMR,
London, UK). The plasmid vector pcIpac was
constructed from pcIneo (Promega, Madison, WI) by
replacement of the BamHI–SmaI fragment carrying the
neomycin resistance gene with the BamHI–PvuII
fragment of pPur (Clontech, Palo Alto, CA) carrying
puromycin resistance. Fusion proteins expressing the
murine CD8a extra-cellular domain, or that of a
chicken CD40-like molecule (AJ293700), fused to
human Ig heavy chain C2 and C3 domains were made
from COS cells transfected with a plasmid constructed
essentially as described elsewhere [21]. The
YTS169.4.2.1 hybridoma, expressing a rat monoclonal
antibody recognising mouse CD8a was obtained
C.A. Tregaskes et al. / Developmental and Comparative Immunology 29 (2005) 361–374362
from the European Collection of Cell Cultures
(ECACC, Porton Down, UK). Hybridoma cultures
were grown in Technomouse (Integra Biosciences,
Chur, Switzerland) cultures with Ig-depleted foetal
calf serum, and the antibodies were purified using a
HiTrap proteinG column (Amersham Biosciences,
Little Chalfont, UK). Oligonucleotides were obtained
from MWG (Ebersberg, Germany) or InVitrogen
(Paisley, UK). The anti-chicken monoclonal
antibodies AV7 (CD28), AV20 (Bu-1), KuL01 (mono-
cyte-macrophage marker) and 11C3 (thrombocyte
marker), all IgG1, have been described elsewhere
[24–27]. Anti-bovine IgG1 isotope control antibodies,
CC29 [28] and CC32 [29], and IgG2a isotype control
antibodies, CC63 [30] and CC101 [31] were from the
Institute for Animal Health.
2.2. Animals
RPRL Line 0 chickens were maintained in the
Poultry Production Unit of the Institute for Animal
Health, and were used at between 6 and 10 weeks of
age. All procedures involving animals were con-
ducted in accordance with the applicable regulations
of the UK Home Office.
2.3. Cell cultures
Cell cultures were maintained in 5% CO2, at 37 8C
for mammalian cells, or at 41 8C for chicken cells.
COS-7 [32] cells were grown and transfected as
described elsewhere [33]. CHO cells [34] were grown
in Ham’s F12 medium (InVitrogen) with 10% FCS.
HD11, a virally transformed chicken macrophage cell
line [35], was cultured in RPMI 1640 medium
(InVitrogen), 7% FCS, 3% chicken serum (Sigma,
Poole, UK). DT40 and DT95 bursal lymphoma lines
[36] were cultured in RPMI 1640, 10% tryptose
phosphate broth, 7% FCS serum, 3% chicken serum,
50 mM b-mercaptoethanol (InVitrogen). To prepare
chicken splenocytes, spleen cells were suspended in
RPMI 1640, centrifuged at 35!g for 10 min at 4 8C,
decanted from pelleted erythrocytes, pelleted by
centrifugation at 400!g for 5 min at 4 8C, and
resuspended in the culture medium, RPMI 1640, 5%
FCS. Activated splenocytes were obtained by layering
spleen cells on histopaque 1077 (Sigma), centrifu-
gation at 2600!g for 15 min at 4 8C, washing, and
culture in RPMI containing 5% FCS, 25 nM PMA
and 1.25 mg/ml ionomycin (both from Calbiochem,
Nottingham, UK) for 24 h.
2.4. Full-length coding sequence of a possible
CD154 (CD40L)
The sequence of EST AI982044 was used to design
PCR primers (CTGATGAAGGGACTTGAC; TCTA-
CAGCTTGAACATGC) to amplify an internal frag-
ment from cDNA libraries in the form of purified
plasmid DNA. A PCR product with the predicted
sequence was obtained from the RPRL line 0 spleen
cDNA library. Library inserts were excised with XhoI
and ligated to XhoI adapters containing a single
nucleotide mismatch (TCGAGGGAATCTTGA-
TATCGAATTCCTGCCGCAGGAATTCGATAT-
CAAGCTTCCC). An adapter primer ending at the
mismatch (GCAGGAATTCGATATCAAGC) was
used with each of the internal primers to amplify the
ends of cDNA inserts from the library. Products were
cloned into pBluescript II SK(C) (Stratagene,
La Jolla, CA) using the adapter XhoI site and a SstI
site within the EST sequence. DNA sequencing
reactions (Amersham) were analysed using ABI
Prism 373 or 377 automated sequencers. Sequence
data was analysed using STADEN [37] and GCG
(Wisconsin Package Version 10.2, Genetics Compu-
ter Group, Madison, WI). Multiple clones of PCR
product were sequenced from each amplification to
obtain the consensus sequence and to identify clones
free from PCR errors. The consensus sequence
obtained was submitted to the EMBL database (Acc.
No. AJ243435). A full length coding sequence was
assembled by inserting KpnI–SstI and SstI–XhoI
fragments, from the 5 0 and 3 0 extended clones,
respectively, into KpnI–XhoI cut pcIpac to yield the
clone pcCD154.
2.5. Fusion proteins
The sequence encoding the extra-cellular domain
of the TNF encoded in pcCD154 was amplified with a
vector primer and the primer GGACTTCGCCATG-
GATAAGATGGAAGAGGTG. The sequence encod-
ing the signal peptide and extra-cellular domain of
mouse CD8a (encoding residues 1–192 of the
precursor peptide sequence; Swissprot: P01731) was
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amplified from a cDNA clone [23] with the primers
GACCTAAGCTTCTTGCTGG, (5 0 of the coding
sequence introducing a HindIII site) and ATCT-
TATCCATGGCGAAGTCCAATCCGGTCC. The
fragments were joined by annealing and extension
of the complementary 20 nucleotides at the 5 0 ends of
the two internal primers, followed by PCR amplifica-
tion with the external primers, and ligated into
pBluescript between HindIII and ApaI sites. After
verification of the sequence in one clone, the insert
was excised with XbaI and KpnI and inserted into
NheI–KpnI cut pcIpac. COS cells transfected with the
resulting plasmid, named pm8c154 (m8 indicating the
N-terminal mouse CD8 domain and c154 the fused
C-terminal chicken CD154 domain of the encoded
fusion protein), were incubated with serum-free
medium from 24 to 72 h after transfection to produce
medium containing fusion protein. CHO cells were
transfected with pm8c154 using Effectene (Qiagen,
Crawley, UK) and plated in culture dishes in which
transfected cells were selected by addition of 20 mg/
ml puromycin (Affiniti Research Products, Exeter,
UK) after 24 h. Surviving colonies were cloned by
limiting dilution in the presence of 15 mg/ml
puromycin.
A mutant fusion protein carrying the single amino
acid substitution (R213M in the full-length cDNA
sequence, Uniprot accession number Q9I8D8) was
produced by PCR amplification of overlapping
segments representing the two ends of the pm8c154
insert with appropriate vector primers and internal
primers which introduced the desired mutation and an
AseI site, without any other changes to the encoded
sequence (forward: CCGGCTATTAATGATGG-
GACTTGACACGCACAG and reverse: CCCTT-
CATTAATAGCCGGTCCTCTTCCATGGGGAG;
mismatches underlined). The two fragments, digested
with AseI and SpeI or NotI, were inserted in a single
ligation into pcIpac cut with NheI and NotI. A clone,
pm8c154x1, was selected after sequence verification
of the TNF domain.
2.6. Fusion protein purification
Twenty milligrams of purified YTS169 anti-mouse
CD8a antibody was coupled to a 5 ml NHS-activated
HiTrap column (Amersham) as specified by the
manufacturer. CHO cell culture supernatants of
4E7-E31 or 9B1, clones transfected with active and
control fusion protein plasmids, produced either in
roller bottles or ‘Miniperm’ vessels (Vivascience,
Hannover, Germany) were loaded onto the YTS169
column, washed with 10 column volumes of PBS and
eluted with 0.1 M glycine/HCl pH 2.7, which was
immediately neutralised with 0.1 volumes of 1 M
Tris/HCl pH 9. After dialysis against PBS, the A280 of
the protein solution was measured and the concen-
tration estimated by using a molar extinction coeffi-
cient of 37350 MK1 cmK1, calculated from the
predicted amino acid composition [38] and a Mr
estimate of 55 kDa for the monomeric glycoprotein.
Purified fusion proteins were directly conjugated
with Alexa-Fluor 488 fluorochrome using the Alexa-
Fluor 488 monoclonal antibody labelling kit as
described in the manufacturer’s protocols (Molecular
Probes, Leiden, Netherlands). Calculations based on
the A280 and A494 indicated that the average number
of molecules of fluorochrome incorporated per
molecule of fusion protein were 2.7 and 2.9 for
m8c154 and m8c154x1, respectively.
2.7. Biochemical analyses
Affinity purified fusion proteins were analysed by
size exclusion chromatography using a Smart system
(Amersham) with a 3.2 mm!30 cm Superose12
column in PBS at a flow rate of 40 ml/min, monitoring
eluting protein by absorbance at 280, 230 and 214 nm.
Both the affinity purified proteins and eluted column
fractions were analysed by PAGE [39].
2.8. Mass spectrometry
A solution of m8c154 (100 ml at 1 mg/ml), was
dialysed into 2 M urea, 100 mM ammonium bicar-
bonate, pH 7.8. Approximately 5% (w/w) trypsin was
added and the solution was incubated overnight at
37 8C. The resulting tryptic peptides were analysed by
online capillary HPLC-mass spectrometry. The capil-
lary column was 180 mm i.d. and was packed with
Hichrom C18 media (3.5 mm bead size, 150 A˚ pore
size). The eluent from the capillary column was
passed, via a uv detector, to a Quattro II tandem
quadrupole mass spectrometer (Micromass, Manche-
ster, UK) equipped with a commercial Z-spray
ionisation source operating in continuous flow
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nanospray mode. The mass spectrometer was scanned
from m/z 350–2100 with a scan time of 4.5 s. To
generate sequence ions from tryptic peptides, these
were desalted by use of a ZipTip (Millipore, Watford,
UK), loaded into a platinum-coated, pulled boro-
silicate glass capillary, and sprayed directly into the
mass spectrometer at a flow rate of around 20 nl/min.
Collision energies between 15 and 30 V were used.
2.9. Monoclonal antibodies and ELISA
Female BalB/c mice were injected in each quad-
riceps with 50 ml 0.25% bupivicaine (Sigma) in PBS
and 1 day later with 50 ml 1 mg/ml pcCD154 in PBS at
the same sites. This was repeated at 30 days. Tail
blood taken at 37 days after primary immunisation
was used in an ELISA of reactivity with protein in
transfected COS cell supernatants. Seventy days after
the initial injection, a final boost was given by intra-
peritoneal inoculation with 0.5 ml of the COS cell
supernatant containing m8c154 fusion protein. Four
days later mice were killed and spleens removed for
fusion with NS0 cells. Hybridoma supernatants were
screened by ELISA with m8c154 fusion protein and
with control murine CD8-human Ig fusion protein.
ELISA was used to detect and measure fusion
proteins and anti-CD154 antibodies, and to test the
binding of fusion proteins to chicken CD40-human Ig.
The chicken CD40-Ig fusion protein was produced
from a chicken CD40 cDNA (accession number
AJ293700) using standard methods. For antibody
and fusion protein assays, purified YTS169, 50 ml at
1 mg/ml in 50 mM sodium bicarbonate buffer pH 9.6,
was used to coat wells of 96-well PVC plates (Falcon
353912, Becton Dickinson, Oxford, UK) for 16–24 h
at 4 8C, and wells were successively incubated for
30 min each, at room temperature, with 50 ml each of
1%BSA in PBS, fusion protein, anti-chicken CD154
antibody, HRP conjugated goat anti-mouse-Ig
(Absorbed with Rat Ig, Serotec, Oxford, UK), and
TMB substrate (Sigma). For receptor-binding activity,
wells were coated with goat anti-human-Ig (Southern
Biotechnology Associates, Birmingham, AL), at
1 mg/ml in bicarbonate buffer as above. Wells were
then incubated with COS cell supernatants containing
chicken CD40-human Ig fusion protein followed, in
succession, by COS cell supernatants containing the
m8c154 or m8c154x1 fusion proteins, YTS169, HRP
conjugated goat anti-rat Ig (Southern Biotechnology
Associates) and substrate. Wells were washed three
times with PBS, 0.05% Tween 20 between all
incubations. Colour development was stopped by
addition of 50 ml of 2 M sulphuric acid, and
absorbance measured at 450 nm. For estimation of
relative concentrations, serial two-fold dilutions of
either fusion protein or anti-CD154 antibody were
used with a saturating concentration of the other
component.
2.10. Flow cytometry
Cells were incubated with the appropriate dilution
of monoclonal antibody, followed by R-PE conju-
gated goat anti-mouse Ig (Southern Biotechnology
Associates). Binding of fusion protein to cells was
detected either by using Alexa-Fluor 488 labelled
fusion protein, or by using unlabelled fusion protein
followed by R-PE conjugated YTS169 monoclonal
antibody (Serotec). Flow cytometry was performed
using a Becton Dickinson FACSCalibur and data
were analysed using WinMDI version 2.8 software
(http://facs.scripps.edu/software.html).
2.11. Biological activities of fusion proteins
Nitrite accumulation in supernatants of HD11
cells, cultured at 4!105 cells per well of a 96 well
plate, was measured using Greiss reagent as described
[40]. The DNA contents of ethanol-permeablised
DT40 cells was measured by staining with propidium
iodide [41]. B cell survival in culture was measured by
staining cells with the monoclonal antibody AV20,
followed by FITC conjugated goat-anti-mouse Ig
(Southern Biotechnology Associates). Live cells were
identified by exclusion of propidium iodide. Flow
cytometry and analysis was carried out as above.
3. Results
3.1. A possible chicken CD154 (CD40L) sequence
The EST AI982044, obtained from a library from
ConA activated T-cells [42], encoded an amino acid
sequence similar to CD154. The full-length coding
sequence corresponding to this EST was obtained from
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a spleen cDNA library using primers internal to the
EST. The peptide sequence encoded by the combined
consensus sequence of PCR products is shown, aligned
with mammalian CD154 sequences, in Fig. 1.
Comparisons of the whole encoded sequence with
those of other TNF superfamily members revealed
higher similarity with CD154 than other family
members, but on its own this was not enough to
identify the molecule as the chicken CD154 ortholo-
gue. In the alignments shown, the chicken sequence
has 44–49% similarity with the mammalian sequences,
the most similar of which is the murine, while the most
dissimilar of the mammalian sequences share 77%
of residues. Apart from the transmembrane region,
the highest similarities are in the TNF domain. Of the
three patches of six or more amino acids identical in all
four species, two are aligned with beta strands that
form inter-monomer contacts in the mouse CD154
trimer (Fig. 1a and b; [43]). The third is unlikely to be
involved either in trimerisation or receptor binding, as
it contains a conserved N-linked glycosylation signal
amongst hydrophobic residues that form the interior of
a depression on the outside of mouse CD154. Thus
conservation of sequence between mammals and
chickens is dominated by the requirements of structure
rather than of receptor-binding function.
Exons encoding the majority of the chicken CD154
cDNA sequence were found in at least six exons
Fig. 1. Alignment of putative chicken CD154 amino acid sequence from pcCD154 (c) with human (h), murine (m) and bovine (b) CD154
sequences. (Swissprot accession numbers h:P29965, m:P27548, b:P51749). Identities in chicken and human sequences are indicated by bars
above. Residues in the murine and bovine sequences identical to those in the human sequence are replaced by dashes. Gaps introduced for the
purposes of alignment are shown by dots. The transmembrane region (TM) is indicated. The sequence present in the EST AI982044 is shown by
a dashed line beneath the chicken sequence. The dashed line below the murine sequence indicates the TNF domain. The large arrow shows the
start of the segment of the sequence included in the fusion protein m8c154. The inverted triangle points to the lysine residue changed to
methionine in the mutant control fusion protein m8c154x1. Boxed residues are cysteines conserved in all the sequences, and the dotted lies
joining them show disulphide bonds confirmed as present in the purified fusion protein. Vertical dotted lines show the boundaries of exons, each
numbered to indicate the phase of the splice junctions in the codon for the following amino acid residue.
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within two adjacent contigs in the preliminary
assembly of the chicken genome sequence (http://
www.nhgri.nih.gov/11510730), although the 5 0 end of
the C-terminal TNF domain-encoding exon was
missing from the genome sequence. In the first draft
assembly of the genome (http://www.ensembl.org/
Gallus_gallus/, version 22.1.1), the splice acceptor
site for the last intron is located in a gap, and
consequenlty the gene (ENSGALG00000006415) is
annotated according to a cDNA carrying a non-splice
deletion, which lacks most of the TNF domain. No
other genes with greater sequence similarity to
mammalian CD154 than to other members of the
TNF superfamily are present in the sequence
assembly. All available intron–exon boundaries of
the chicken CD154 gene had normal splice donor and
acceptor sites, and all were in the same phase as the
equivalent exons of mouse and human CD154 genes.
As shown in Fig. 1, the chicken gene contains an
additional exon, and thus a longer region separating
the TNF domain from the transmembrane region. The
extra sequence is hydrophilic and contains one
potential site for N-linked glycosylation. It is there-
fore likely to be part of a longer flexible stem than
those present in the mammalian proteins.
3.2. Construction of plasmids encoding mouse
CD8-chicken CD154 fusion proteins
To investigate the functional consequences of
signalling by the putative chicken CD154 molecule
we produced a fusion protein analogous to the CD8-
CD154 construct used in studies of mammalian
CD154 [18], which was shown to form both trimers
and hexamers in solution [20]. A full-length coding
sequence was reconstructed in the expression vector
pcIpac to yield the plasmid pcCD154, and a chimaeric
sequence with the mouse CD8a extra-cellular region
fused to the extra-cellular region of the putative
chicken CD154 sequence (Fig. 1) was introduced into
the same vector to produce the plasmid pm8c154. We
use the naming scheme with ‘m8’ to indicate the N-
terminal mouse CD8a domain and ‘c154’ to denote
the C-terminal chicken CD154 domain, for the fusion
proteins, with the prefix p to indicate a plasmid
encoding the protein. The ideal control would be a
protein of near identical structure with a specific
defect in receptor binding. Therefore we modelled
the chicken TNF domain by homology with human
CD154, and identified a lysine residue equivalent to
arginine 217 in the human protein (Fig. 1), whose
replacement by methionine abolishes activity in
mammalian CD154 but maintains trimerisation [44].
A mutant control protein, m8c154x1 (x1 indicating
the mutation), was produced in which this lysine was
likewise replaced by methionine.
3.3. Monoclonal antibodies recognising chicken
CD154 fusion proteins
A large number of hybridomas were obtained after
DNA immunisation of mice with pm8c154 and
boosting with the m8c154 fusion protein. Most of
these secreted antibodies that bound to the m8c154
fusion protein, but not to a control CD8Ig fusion
protein. Six of these, named AV71–AV76, were twice
cloned by limiting dilution. The fusion protein
m8c154, present in the supernatant of COS cells
transfected with pm8c154, bound both the mono-
clonal antibody AV71 and chicken CD40-Ig fusion
protein, while the control m8c154x1 fusion protein
was recognised by AV71, but did not bind chicken
CD40-Ig (Fig. 2).
Fig. 2. Binding of anti-chicken CD154 mAb AV71, and of chicken
CD40-human Ig fusion proteins to m8c154 and m8c154x1 fusion
proteins in transfected COS cell supernatants. Binding to CD40-Ig
fusion protein (triangles, left hand scale) was measured by capture
with CD40-Ig bound to anti-Human Ig, and detection with YTS169
mAb. Binding to AV71 mAb (squares, right hand scale) was
detected by capture with YTS169 and detection with AV71. Two-
fold dilutions of the same transfected COS cell supernatants
containing m8c154 (solid symbols) or m8c154x1 (open symbols)
were used in both assays at the same time.
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3.4. Expression of CD154 (CD40L) on activated
chicken T-cells
Spleen cells were activated with PMA and
ionomycin for 24 h before staining with the antibodies
AV71–76 or isotype matched control antibodies. The
population of blasting cells, detected by high forward
scatter, contained 60% CD8C and 10% CD4C cells.
Five of the monoclonal anti-chicken CD154 anti-
bodies detected low levels of expression on the
surface of these activated cells (Fig. 3), while they did
not detect expression on the freshly isolated or control
cells (not shown). We did not discern differences in
the staining of CD8C or CD4C cells in double-
staining experiments (not shown).
3.5. Biochemical properties of chicken CD154 fusion
proteins
To produce large amounts of recombinant fusion
protein, CHO cells were transfected with the plasmids
pm8c154 or pm8c154x1. Cells expressing high levels
of either fusion protein were obtained from several
thousand initial colonies, cloned by limiting dilution
and screened by ELISA of culture supernatants. Both
fusion proteins were purified from CHO cell super-
natants by affinity chromatography using immobilised
YTS169, anti-mouse CD8a antibody. Analysed by
PAGE, the affinity purified m8c154 protein appeared
to consist of a single component with an apparent Mr
of 55 kDa (Fig. 4C). A second, minor, component
with an apparent Mr of 52 kDa was present in
independent preparations of the m8c154x1 protein
preparation (Fig. 4D).
To compare the oligomerisation state of the two
proteins, both were analysed by size exclusion
chromatography (Fig. 4A and B). Peaks representing
approximate sizes of 50, 150 and 300 kDa were
evident in these separations, as well as a variable
amount of larger excluded material. No components
resolvable from the fusion protein were detected in
any of these fractions by PAGE. Therefore we assume
that these components represent a small amount of
monomer, in the shoulder at 50 kDa, trimer, hexamer,
and larger aggregates of the fusion protein. The
oligomerisation state of the two preparations was
similar, with similar ratios of material in the trimer
and hexamer peaks, although there was more
aggregated material in the control protein preparation.
The monomer was more evident in the product from
another CHO cell clone expressing 1/100 the level of
m8c154, perhaps as the result of lower intra-cellular
concentration (not shown).
In order to confirm the primary sequence of the
fusion proteins, and the single amino acid replacement
in m8c154x1 the affinity purified fusion proteins
were digested with trypsin and resulting peptides
analysed by capillary HPLC-MS. Various peptides,
covering the majority of the sequence of the proteins,
were identified based on their mass. The predicted
N-terminus of the murine CD8a moiety was con-
firmed. Digestion of m8c154 liberated a peptide of
mass 2433.65 Da corresponding to residues 308–328
(theoretical mass 2433.19 Da) and resulting from
cleavage after Lys331. In m8c154x1, this lysine
residue has been mutated to a methionine residue,
preventing tryptic cleavage. This was confirmed by
the lack of a peptide of this mass and the presence
instead of a peptide of mass 2893.80 Da correspond-
ing to residues 308–332 (theoretical mass
2893.44 Da). A number of peptides containing
disulphide linkages were identified by comparison
of peptide profiles before and after reduction with
DTT. Specifically, we found disulphide bonds linking
cysteines 187–200, and 305–344. The identities of
these peptides were confirmed by collision activation
experiments and analysis of the resulting fragment
ions. Their positions are shown in Fig. 1. A number of
Fig. 3. Expression of m8c154 binding activity on activated chicken
T-cells. Splenocytes cultured for 25 h in the presence of 25 mg/ml
Phorbol Myristate Acetate (PMA) and 1.25 mg/ml Ionomycin were
stained with either: (A) IgG1 antibodies AV71 or AV74 (solid lines)
or isotype-matched controls CC32 or CC29 (dotted lines); or (B)
IgG2a antibodies AV72, AV73 or AV75 (solid lines) or isotype
matched control CC8. The histograms show fluorescence of blasting
cells gated for high forward scatter.
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peptides that gave fragment ions consistent with
glycosylation were also identified.
3.6. Expression of a receptor for CD154 on chicken
cells
Expression of receptors binding the m8c154
protein was detected by flow cytometry of cells
from various tissues double-stained with fluorescent
fusion protein or control fusion protein and with cell-
lineage-specific antibodies. Specific binding of
m8c154, but not the mutant control, was observed
with all AV20C B-cells from bursa, spleen and PBL,
at increasing levels in this series of tissues (Fig. 5A).
In PBL, T-cells, recognised by AV7, did not bind the
fusion protein, but all monocytes or macrophages,
recognised by KUL01, did express high levels of
receptor (Fig. 5B). Thrombocytes, detected by 11C3
binding, appeared to bind the fusion protein, albeit at
much lower levels than the other positive cell
populations (Fig. 5B). This low level expression on
thrombocytes was confirmed by observing the stron-
ger staining with fusion protein and YTS169 (not
shown). Specific staining with the normal fusion
protein was also seen on cell lines representing
macrophages (HD11) and both immature B-cells
(DT40) and more mature B-cells (DT95), but not on
the T-cell line HP9 (Fig. 5C).
3.7. Biological activities of chicken CD154 fusion
protein
We examined the activity of m8c154 in three
in-vitro assays. CD40 signalling to mammalian
macrophages causes the production of NO [45]. To
assay for this response to m8c154, accumulation of
Fig. 4. Biochemical analysis of affinity-purified fusion proteins. (A, B) Normalised traces of the A230 of eluate from the Superose12 column as a
function of time, shown in minutes on the horizontal axis, for m8c154 (A) and m8c154x1 (B). Vertical lines indicate the positions of peaks
interpreted as representing monomer (m), trimer (t), hexamer (h) and larger aggregates excluded from the column matrix (x). (C, D)
Photographs of coomassie-blue stained PAGE analysis of the products of three separate batches of each affinity purified fusion protein m8c154
(C) and m8c154x1 (D). The migration of standards with the indicated Mrs in the same gel are shown to the right.
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nitrite in the supernatants of the HD11 chicken
macrophage cell line cultured for 48 h in the presence
of varying concentrations of m8c154 or m8c154x1
was measured (Fig. 6A). The m8c154 protein was
active in inducing NO production in this cell line, with
half-maximal activity at a concentration of approxi-
mately 0.3 mg/ml and maximal activity at concen-
trations above 3 mg/ml. The control m8c154x1 fusion
protein did not induce detectable NO production at
any concentration up to 40 mg/ml. The possibility that
the control fusion protein might contain an inhibitory
component was excluded by the observation that
activity of m8c154 over this range of concentrations
was not inhibited by the inclusion of 20 mg/ml of the
control fusion protein (not shown).
The outcomes of CD40 signalling to mammalian
B-cells depends on the developmental stage and
other intra- and extra-cellular factors. In most cases
it leads to increased survival and proliferation [46],
but it may also lead to apoptosis, especially at high
levels receptor cross-linking [47]. To observe the
effects of the m8c154 fusion protein on the survival
of mature B-cells, splenocytes were cultured with
either the active or control fusion protein (Fig. 6B).
The proportion of surviving B-cells, identified by
surface staining with Bu-1 antibody AV20, was
measured by exclusion of propidium iodide. The
proportion of B-cells in the surviving cell popu-
lation after 48 or 120 h was unaffected by the
presence of the control m8c154x1 fusion protein
over the whole range of concentrations tested.
At concentrations of the active m8c154 fusion
protein lower than 1 mg/ml, the proportion of
surviving B-cells at both 48 and 120 h increased
Fig. 5. Expression of m8c154-binding receptors on cells from bursa, spleen, PBL and cell lines. (A) Expression on B-cells. Each pair of dot-plots
shows staining with Alexa-Fluor 488-labelled control mutant fusion protein m8c154x1 (left) or m8c154 (right) on the horizontal axis, and with
AV20 on the vertical axis. (B) Double staining of PBL with specific markers for T-cells (AV7), monocytes/macrophages (KUL01) or
thrombocytes (11C3) on the vertical axis, and with mutant and normal fusion proteins on the horizontal axis. (C) Distributions of fluorescence
intensities of cell lines HP9, HD11, DT40 and DT95 stained with Alexa-Fluor 488-labelled control m8c154x1 (dotted line) or m8c154 (solid line).
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in a dose-dependent manner. With increasing concen-
trations above 1 mg/ml, the enhanced survival was
reduced (48 h), or abolished (120 h). Similar
experiments with bursal B-cells (not shown) did not
reveal reduction in the rapid apoptosis of these cells
after removal from the bursa [48].
The effect of treatment of the bursal lymphoma cell
line DT40 with m8c154 and control fusion proteins
was investigated. Estimation of the proportion of
apoptotic cells, with less than 2 N DNA content, in
these cultures revealed a dose-dependent induction of
apoptosis without the requirement for BCR signalling
(Fig. 7). Half-maximal induction was apparent at a
concentration similar to that required for half-
maximal induction of NO in HD11 cells, but
saturation of the effect was not evident even at
much higher concentrations. The control fusion
protein had no effect on the level of apoptosis over
the range of concentrations tested.
4. Discussion
Sequence similarity of the chicken TNF family
molecule described here with mammalian TNF family
members suggest that it is the evolutionary orthologue
of mammalian CD154. This is further supported
by the location of the gene within a region of
chicken chromosome 4 having conserved synteny
with the location of the CD154 gene on the human
X chromosome. This enabled us to ask whether the
functional properties of these orthologous genes had
been conserved since the divergence of mammals and
avian species. Mammalian CD154 was initially
described as expressed on activated CD4C T-cells,
but has since been shown to be expressed on other cell
types, including a proportion of activated CD8C
T-cells [12]. The chicken molecule was found to be
expressed on activated T-cells, but the low intensity of
staining by our antibodies prevented us from showing
differences between expression on CD4C and CD8C
subsets. Since the majority of the blasting cell
population examined were CD8C cells, it is likely
that a larger proportion of chicken CD8C cells than
mammalian CD8C cells express this molecule upon
activation.
To investigate the distribution of the receptor, and
the biological activities of the chicken CD154
molecule, we prepared a soluble multimeric fusion
Fig. 7. Biological activity of m8c154: induction of apoptosis in
DT40 cells. Distributions of propidium iodide fluorescence in fixed
DT40 cells cultured for 24 h in the presence of serial two-fold
dilutions of m8c154 fusion protein, or control m8c154x1, were
determined by flow cytometry. Example histograms are shown, with
the fusion protein concentrations indicated (mg/ml), from the
m8c154 series (A) and the m8c154x1 series (B). Horizontal axes
show fluorescence intensity on a logarithmic scale covering four
log10. Bars indicate regions used to estimate the percentage of
counted events representing cells with lower than 2N DNA content.
The graph (C) shows these percentages on the vertical axis, with the
fusion protein concentrations on the horizontal axis (mg/ml).
Fig. 6. Biological activity of m8c154. (A) Activation of HD11 cells
by m8c154 fusion protein. The vertical axis shows the colour
development in the NO production assay from supernatants of
HD11 cultures incubated with serial two-fold dilutions of affinity-
purified m8c154 fusion protein (solid squares) or control m8c154x1
(open squares). (B) Enhanced survival of spleen B-cells in culture.
The vertical axis shows the percentage of live cells that are stained
with AV20 mAb in splenocytes cultured for 48 h (triangles) or
120 h (squares), in the presence of three-fold dilutions of affinity-
purified fusion proteins (solid m8c154, open m8c154x1). Bars show
the range for triplicate samples. The horizontal axes are labelled
with fusion protein concentration (mg/ml) estimated from the A280.
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protein, and a novel control protein with a single
amino acid substitution that abolished receptor
binding but did not interfere with the oligo-
merisation. Both fusion proteins accumulated in the
supernatants of transfected CHO cells as a mixture,
predominantly of trimers and hexamers, when
expressed at high levels. Mass spectrometry, used to
confirm the structures of the fusion proteins, revealed
a disulphide bond, between cysteine residues con-
served in all species, in the disordered ’stalk’ region
of the chicken fusion protein. The presence of this
disulphide bond has not been documented in mam-
malian CD154.
Active and control fluorochrome-labelled m8c154
fusion proteins were used to detect specific binding to
chicken B-cells and B-cell lines as well as mono-
cytes/macrophages and a macrophage cell line, but
not to T-cells, consistent with binding to a receptor
with similar expression profile to mammalian CD40.
We also observed a low level of binding to
thrombocytes, which in mammals express CD40
constitutively [49] and mobilise intra-cellular
CD154 to their surface on activation [50]. Chicken
thromobocytes are very different from mammalian
platelets in that they are nucleated and have other
unusual properties [51,52]. Examination of the effects
of CD40 signalling on thrombocytes may reveal
special functions in the chicken. We did not detect
binding of the chicken CD154 to mammalian B-cells
(data not shown).
The biological activities of the m8c154 fusion
protein included induction of NO production by
macrophages, as with mammalian CD40L [45]. At
low concentrations the fusion protein increased the
number of surviving B-cells in cultured chicken
splenocytes, but this effect was reversed at higher
concentrations. Opposing effects of CD40L on B-cell
survival at different concentrations have been
observed in mammalian cells [47].
There is no equivalent in mouse or human of the
bursal stage of B-cell development in chickens,
during which proliferating cells diversify their Ig
genes by gene conversion [14]. Some immature
mammalian B-cells can be maintained in culture by
CD40 signalling [53] and immature B cell lines can
be protected from apoptosis induced by Ig cross-
linking [54]. Bursal B-cells rapidly enter apoptosis
when removed from the bursal environment [45].
We did not observe any effect of the m8c154 fusion
protein on the survival of bursal B-cells in culture.
The immature bursal lymphoma cell line DT40,
whose properties resemble those of B-cells at the
bursal stage of development [55], can be induced into
apoptosis by cross-linking surface IgM [56]. In
attempting to determine whether m8c154 could
block BCR signalling induced apoptosis in this cell
line, we found that the m8c154 fusion protein alone
was sufficient to cause an increase in the rate of cell
death. The induction of cell death by CD40L in a
number of transformed mammalian cells, including
lymphoma cells, has been reported [57,58]. Thus the
response of DT40 may be equivalent to that of EBV-
transformed human B-cells, in which CD40 signal-
ling can induce apoptosis [59].
Many of the extant features of vertebrate immune
systems, as most intensively studied in mouse and
human, are the products of relatively recent evolution,
and alternative choices of the molecular machinery
involved in recognisably similar functions may have
been taken in even closely related species. Perhaps the
most striking example is provided by the inhibitory
NK receptors, the Ly49 family in mice and the KIR
family in humans, where equivalent functions are
carried out by very different protein families [60].
Over the much longer timescale that separates
chickens and mammals from their common ancestors,
there are likely to be more and greater differences in
the functions of recognisably orthologous molecules.
In addition to its sequence and the conserved
chromosomal location of the chicken CD154 ortho-
logue we have described, its expression on activated
T-cells, detection of the receptor on macrophages and
B-cells, and comparable activities in functional
assays, lead to the conclusion that this molecule is
also functionally equivalent to mammalian CD154.
Since these functional properties have been conserved
since the divergence of mammals and chickens, it is
reasonable to conclude that they were already
associated with this molecule in the common ancestral
immune system.
The functional protein produced in this investi-
gation will have an important role in investigation of
the evolution of the function of antigen presenting
cells and of the regulation of immunoglobulin class
switch recombination.
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